Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19
Clinical trial NCT04438057 · COMPLETED
Trial details
- NCT number
- NCT04438057
- Sponsor
- Metro Infectious Disease Consultants
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2020-08-12
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.